Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lee

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Diabetes Technology & Therapeutics|August 4, 2015
Upcoming Devices for Diabetes Management: The Artificial Pancreas as the Hallmark DeviceScott W Lee, John B Welsh
Critical Care Nursing Quarterly|May 13, 2004
Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapyScott W Lee, Richard Im, Richard Magbual
Journal of Diabetes Science and Technology|April 28, 2012
Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithmJohn B Welsh, Francine R Kaufman, Scott W Lee
Journal of General Internal Medicine|May 6, 2009
Retrospective analysis of diabetes care in California Medicaid patients with mental illnessJim E Banta, Elaine H Morrato, Scott W Lee, et al.
Diabetes Technology & Therapeutics|December 8, 2017
Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c ReductionRudolf Chlup, Sarah Runzis, Javier Castaneda, et al.
Diabetes Technology & Therapeutics|June 15, 2017
Automated Insulin Delivery System NomenclatureOhad Cohen, Robert A Vigersky, Scott W Lee, et al.
Journal of Diabetes Science and Technology|April 28, 2012
User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for DiabetesJohn B Welsh, Samantha J Myers, Abby N Uhrinak, et al.
Lancet (London, England)|July 7, 2014
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trialYves Reznik, Ohad Cohen, Ronnie Aronson, et al.
Primary Care Diabetes|September 14, 2010
Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysisPeter Lynch, Aylin Altan Riedel, Navendu Samant, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experienceScott W Lee, Tom Sweeney, Debbie Clausen, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Diabetes Technology & Therapeutics|August 4, 2015
Upcoming Devices for Diabetes Management: The Artificial Pancreas as the Hallmark DeviceScott W Lee, John B Welsh
Critical Care Nursing Quarterly|May 13, 2004
Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapyScott W Lee, Richard Im, Richard Magbual
Journal of Diabetes Science and Technology|April 28, 2012
Accuracy of the Sof-sensor glucose sensor with the iPro calibration algorithmJohn B Welsh, Francine R Kaufman, Scott W Lee
Journal of General Internal Medicine|May 6, 2009
Retrospective analysis of diabetes care in California Medicaid patients with mental illnessJim E Banta, Elaine H Morrato, Scott W Lee, et al.
Diabetes Technology & Therapeutics|December 8, 2017
Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c ReductionRudolf Chlup, Sarah Runzis, Javier Castaneda, et al.
Diabetes Technology & Therapeutics|June 15, 2017
Automated Insulin Delivery System NomenclatureOhad Cohen, Robert A Vigersky, Scott W Lee, et al.
Journal of Diabetes Science and Technology|April 28, 2012
User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for DiabetesJohn B Welsh, Samantha J Myers, Abby N Uhrinak, et al.
Lancet (London, England)|July 7, 2014
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trialYves Reznik, Ohad Cohen, Ronnie Aronson, et al.
Primary Care Diabetes|September 14, 2010
Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysisPeter Lynch, Aylin Altan Riedel, Navendu Samant, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experienceScott W Lee, Tom Sweeney, Debbie Clausen, et al.
Pageof 4